Bruker Corporation to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Bruker Corporation (Nasdaq: BRKR) will participate in the 40^th annual J.P. Morgan Healthcare Conference, scheduled for January 10-13, 2022. The Company’s Chairman and CEO, Frank Laukien, along with Executive Vice President and CFO, Gerald Herman, will present on January 10 at 9:00 AM EST. A live audio webcast of this presentation will be accessible on the Investor Relations section of Bruker's website, with a replay available for 30 days post-event. Bruker focuses on high-performance scientific instruments, enhancing life sciences research and diagnostics.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the 40^th annual J.P. Morgan Healthcare Conference, to be held virtually on January 10-13, 2022. Frank Laukien, Chairman, President & CEO and Gerald Herman, Executive Vice President & CFO will present on behalf of the Company on Monday, January 10^th, 2022 at 9:00 AM Eastern Standard Time.

A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.

About Bruker Corporation (Nasdaq: BRKR)

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220104005381/en/

Investor Contact:

T: +1 (978) 663-3660 x1479

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When is Bruker Corporation presenting at the J.P. Morgan Healthcare Conference?

Bruker Corporation will present on January 10, 2022, at 9:00 AM EST.

Where can I watch the Bruker Corporation presentation?

The presentation can be watched live on the Investor Relations section of Bruker's website.

How long will the Bruker Corporation presentation be available for replay?

The replay of the presentation will be available for 30 days after the event.

Who will represent Bruker Corporation at the J.P. Morgan Healthcare Conference?

Frank Laukien, Chairman and CEO, and Gerald Herman, Executive Vice President and CFO will represent Bruker.

What is the focus of Bruker Corporation's services?

Bruker Corporation specializes in high-performance scientific instruments and solutions for life science research, diagnostics, and material analysis.